| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Molecular Physiology, University of Vermont, Burlington, Vermont, United States
2 Molecular Physiology and Biophysics, University of Vermont, Burlington, Vermont, United States
3 Dept. of Genetics, Harvard Medical School, Cambridge, Massachusetts, United States
4 Sr Bernice Research Programme in Inherited Heart Diseases, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
5 Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, United States
6 Harvard Medical School, Dept. of Genetics, Boston, Massachusetts, United States
7 Physiology and Biophysics, University of Vermont, Burlington, United States
* To whom correspondence should be addressed. E-mail: palmer{at}physiology.med.uvm.edu.
Male (M) but not female (F) mice carrying a single R403Q missense allele for cardiac 
-myosin heavy chain (MHCR403Q/+ ) develop significant hypertrophic cardiomyopathy (HCM) compared to wildtype mice (MHC+/+) after about 30 wks of age. We tested the hypothesis that myofilament mechanical performance differs between M-MHCR403Q/+ and F-MHCR403Q/+ at younger ages (10-20 wks) and could account for gender-differences in HCM development. The sensitivity of chemically-skinned myocardial strips to calcium activation (pCa50) was significantly (P<0.05) enhanced in M mice independent of genotype (M-MHCR403Q/+ 5.70±0.06; M-MHC+/+ 5.63±0.05; F-MHCR403Q/+ 5.57±0.03; F-MHC+/+ 5.54±0.04) by two-way ANOVA, while maximum developed tension (Tmax) was significantly enhanced in MHCR403Q/+ independent of gender (M-MHCR403Q/+ 29.3±2.3; M-MHC+/+ 26.0±1.4; F-MHCR403Q/+ 30.2±2.1; F-MHC+/+ 26.2±1.2 mN.mm-2). The frequency of maximum work generated by sinusoidal length perturbation was significantly higher in MHCR403Q/+ compared to gender-matched controls (M-MHCR403Q/+ 2.26±0.47; M-MHC+/+ 1.29±0.18; F-MHCR403Q/+ 3.21±0.33; F-MHC+/+ 2.52±0.36 Hz). Unloaded shortening velocity (Vslack) was significantly enhanced in MHCR403Q/+ and in F mice (M-MHCR403Q/+ 2.26±0.47; M-MHC+/+ 1.29±0.18; F-MHCR403Q/+ 3.21±0.33; F-MHC+/+ 2.52±0.36 ML/s), and normalized mechanical power (Pmax), calculated from the tension-velocity relationship, was significantly enhanced in MHCR403Q/+ independent of gender (M-MHCR403Q/+ 60±2 10-3; M-MHC+/+ 37±3 10-3; F-MHCR403Q/+ 57±3 10-3; F-MHC+/+ 25±3 10-3 ML/s x T/ Tmax). We did not find a statistically significant gender x mutation interaction for any measure of myofilament performance. Therefore, sarcomeric incorporation of the R403Q myosin similarly enhanced LV myofilament mechanical performance in both M and F. The gender-dependent development of HCM due to the R403Q myosin may then be inhibited by female sex hormones, which may additionally underlie the observed gender differences for pCa50 and Vslack.
This article has been cited by other articles:
|
|
 |
|
  T. Suzuki, B. M. Palmer, J. James, Y. Wang, Z. Chen, P. VanBuren, D. W. Maughan, J. Robbins, and M. M. LeWinter Effects of Cardiac Myosin Isoform Variation on Myofilament Function and Crossbridge Kinetics in Transgenic Rabbits Circ Heart Fail, July 1, 2009; 2(4): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
